Determination of ultrafilterable prolactin: Elimination of macroprolactin interference with a monomeric prolactin-selective sample pretreatment

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 12, 2006, Pages 1807-1812

  Quinn, Adam M ^a,b   Rubinas, Tara C ^a   Garbincius, C Jean ^a   Holmes, Earle W ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b ACKERMAN ACADEMY OF DERMATOPATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN; MACROPROLACTIN; MONOMER; PROLACTIN; RECOMBINANT HUMAN PROLACTIN;

ADULT; ARTICLE; CENTRIFUGATION; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GALACTORRHEA; GEL FILTRATION CHROMATOGRAPHY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMMUNOASSAY; IMMUNOREACTIVITY; INFERTILITY; INTERFERENCE; MENSTRUAL IRREGULARITY; NEURORADIOLOGY; PROLACTIN BLOOD LEVEL; ULTRAFILTRATION;

ADULT; FEMALE; HUMANS; HYPERPROLACTINEMIA; IMMUNOASSAY; PROLACTIN; SPECIMEN HANDLING; ULTRAFILTRATION;

EID: 33845381501     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Molitch ME. Disorders of prolactin secretion. Endocrinol Metab Clin North Am. 2001;30:586-610.
2. Suh HK, Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab. 1974;39:928-935.
3. Kiefer KA, Malarkey WB. Size heterogeneity of human prolactin in CSF and serum: experimental conditions that alter gel filtration patterns. J Clin Endocrinol Metab. 1978;46:119-124.
4. Sinha YN. Structural variants of prolactin: occurrence and physiological significance. Endocrinol Rev. 1995;16:354-369.
5. Kline JB, Clevenger CV. Identification and characterization of the prolactin-binding protein in human serum and milk. J Biol Chem. 2001;276:24760-24766.
6. Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem. 2003;49:1504-1509.
7. Vallette-Kasic S, Morange-Ramos I, Selim A, et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab. 2002;87:581-588.
8. Toldy E, Locsei Z, Szabolcs I, et al. Macroprolactinemia: the consequences of a laboratory pitfall. Endocrine. 2003;22:267-273.
9. Guitelman M, Colombani-Vidal ME, Zylbersztein CC, et al. Hyperprolactinemia in asymptomatic patients is related to high-molecular-weight posttranslational variants or glycosylated forms. Pituitary. 2002;5:255-260.
10. Cattaneo F, Kappeler D, Muller B. Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia. Swiss Med Wkly. 2001;131:122-126.
11. Schlechte JA. The macroprolactin problem. J Clin Endocrinol Metab. 2002; 87:5408-5409.
12. John R, McDowell IF, Scanlon MF, Ellis AR. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clin Chem. 2000;46:884-885.
13. Amadori P, Dilberis C, Marcolla A. All the studies on hyperprolactinemia should not forget to consider the possible presence of macroprolactinemia. Eur J Endocrinol. 2004;150:93-94.
14. Fahie-Wilson MN. In hyperprolactinemia, testing for macroprolactin is essential. Clin Chem. 2003;49:1434-1436.
15. Li X, Sustarsic D, Fahie-Wilson MN, et al. Matrix effect of PEG precipitation in detection of macroprolactin in immulite and immulite 2000 prolactin assays. Clin Chem. 2000;48(suppl 6):A62.
16. Schlechte JA. Prolactinomas. N Engl J Med. 2004;350:1054-1056.
17. Strachan MW, Teoh WL, Don-Wauchope AC, Seth J, Stoddart M, Beckett GJ. Clinical and radiological features of patients with macroprolactinaemia. Clin Endocrinol. 2003;59:339-346.
18. Quinn AM, Rubinas TC, Garbincius J, Holmes EW. Determination of serum molecular forms of prolactin by ultrafiltration [abstract]. Program of the 85th Annual Meeting of the Endocrine Society; June 19, 2003; Philadelphia, Pa.
19. Prazeres S, Santos MA, Ferreira HG, Sobrinho LG. A practical method for the detection of macroprolactinaemia using ultrafiltration. Clin Endocrinol. 2003; 58:686-690.
20. Whitaker MD, Klee GG, Kao PC, Randall RV, Heser DW. Demonstration of biological activity of prolactin molecular weight variants in human sera. J Clin Endocrinol Metab. 1984;58:826-830.
21. Allolio B, Hoeppener A, Leonhardt U, Deuss U, Winkelmann W. Size heterogeneity of immunoreactive prolactin in patients with prolactinoma. Acta Endocrinol. 1987;114:475-482.
22. Leite V, Cosby H, Sobrinho LG, Fresnoza MA, Santos MA, Friesen HG. Characterization of big, big prolactin in patients with hyperprolactinaemia. Clin Endocrinol. 1992;37:365-372.
23. Jackson RD, Wortsman J, Malarkey WB. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab. 1985;61:258-264.
24. Hekim C, Alfthan H, Leinonen JT, Stenman U. Effect of incubation time on recognition of various forms of prolactin in serum by the DELFIA assay. Clin Chem. 2002;48:2253-2256.
25. Tritos NA, Guay AT, Malarkey WB. Asymptomatic 'big' hyperprolactinemia in two men with pituitary adenomas. Eur J Endocrinol. 1998;138:82-85.
26. Brue T. Author's response: macroprolactinemia revisited, a study on 106 patients. J Clin Endocrinol Metab. 2002;87:4834.